Which of the following drug for moderate-to-severe psoriasis inhibits both IL-12 and IL-23?
Correct Answer: Ustekinumab
Description: Alefacept is anti CD-2 for psoriasisEfalizumab is anti CD-11a for psoriasisUstekinumab targets the p40 subunit of both IL-12 and IL-23 in psoriasisAbatacept is anti CD-80 and CD-86 for severe RA
Category:
Microbiology
Get More
Subject Mock Tests
Practice with over 200,000 questions from various medical subjects and improve your knowledge.
Attempt a mock test nowMock Exam
Take an exam with 100 random questions selected from all subjects to test your knowledge.
Coming SoonGet More
Subject Mock Tests
Try practicing mock tests with over 200,000 questions from various medical subjects.
Attempt a mock test now